Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 80 clinical trials
Featured trial
  • 513 views
  • 02 Sep, 2021
  • 1 location
Featured trial
A Phase 4, Double-Blind, Randomized, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With Overactive Bladder (OAB) Symptoms While Taking the Alpha Blocker Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH). NCT02757768, 178-MA-1008.

lower urinary tract symptoms (LUTS) due to Benign Prostatic Hyperplasia (BPH). At Screening (Visit 1), subjects will enter into a 4-week open label tamsulosin hydrochloride 0.4 mg QD run-in period

mirabegron
lower urinary tract symptoms
incontinence
tamsulosin
  • 205 views
  • 02 Sep, 2021
  • 1 location
Featured trial
PLUS 1 Study

PLUS 1 Study

  • 249 views
  • 08 Nov, 2020
  • 1 location
The Effect of BRIZO on Lower Urinary Tract Symptoms (LUTS) Related to Benign Prostatic Hypertrophy (BPH)

A randomized, placebo controlled double-blind, 12-week treatment trial in men with moderate to severe symptoms of benign prostatic hyperplasia. The trail is about to examine the effect of Brizo®

  • 0 views
  • 22 Jul, 2022
  • 1 location
  • 2 views
  • 20 Jun, 2021
  • 3 locations
ProVee Urethral Expander System IDE Study (ProVIDE) (ProVIDE)

to benign prostatic hyperplasia (BPH).

Accepts healthy volunteers
  • 0 views
  • 09 Aug, 2022
  • 1 location
A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patients Without Metastasis

Current agents administered in therapeutic regimens of prostate cancer employ different mechanisms to eliminate neoplastic cells by inducing substantial apoptosis and causing tumor regression. Treatment with neoadjuvant chemotherapy before radical prostatectomy may better control the tumor before it has the chance to convert into the disease of castration-resistant prostate cancer …

  • 5 views
  • 14 May, 2022
  • 2 locations
Targeted Microwave Focal Therapy

Focal therapy (FT) for prostate cancer (PCa) is an interesting therapeutic option for localized disease with a favorable low- to intermediate-risk profile. The aim of this approach is to offer a personalized and less aggressive treatment as compared to radical treatments such as radical prostatectomy (RP) or primary radiation therapy, …

  • 4 views
  • 09 Mar, 2022
  • 1 location
Prophylactic Tamsulosin in Prevention of Post-operative Urinary Retention in Men After Transanal Endoscopic Microsurgery (TEMPOUR)

Post-operative urinary retention (POUR) is a frequent complication reported as ranging from 10 to 55% in the literature. In a recent retrospective study from Laliberte et al in Quebec City, we observed that 19% of the patients operated using transanal endoscopic microsurgery (TEM) had a post-operative urinary retention (POUR). Factors …

Accepts healthy volunteers
  • 290 views
  • 31 Jan, 2022
  • 1 location
Efficacy and Safety of DKF-313 in Patients With Benign Prostatic Hyperplasia

benign prostatic hyperplasia.

hyperplasia
benign prostatic hyperplasia
transrectal ultrasound
  • 0 views
  • 15 Dec, 2021
  • 1 location